Answers are grounded in this paper and cite their sources.
This editorial discusses a novel method for assessing site-specific bone marrow metabolic activity in cardiovascular disease models, highlighting its potential to uncover new therapeutic targets.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lanzer et al. (2026) conducted an editorial in Cardiovascular disease. MarrowMet was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: